8 results
Differential Diagnosis of Hemoptysis #Diagnosis #EM #IM #InfectiousDisease #Pulmonary #Hemoptysis #Extrapulmonary #Differential #Algorithm #Assessment #Ddxof
Hemoptysis #Diagnosis #EM ... InfectiousDisease #Pulmonary ... #Hemoptysis #Extrapulmonary ... #Differential #Algorithm ... #Assessment #Ddxof
Pulmonary and Non-Pulmonary Causes of ARDS #Diagnosis #EM #PCC #ARDS #Differential #Algorithm #Pulmonary #NonPulmonary #Causes #Ddxof
Pulmonary and Non-Pulmonary ... ARDS #Diagnosis #EM ... #Differential #Algorithm ... #Pulmonary #NonPulmonary ... #Causes #Ddxof
Causes of Dyspnea - Differential Diagnosis Algorithm
Cardiac:
 • Dysrhythmia
 • Ischemia
 • Cardiomyopathy
 • Valvular disease
Differential Diagnosis Algorithm ... Pneumonia • Pulmonary ... Emphysema • Cancer ... Reduced P102 • Extrapulmonary ... Differential #Diagnosis #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... of cancer-associated ... thrombosis; PE = pulmonary ... #Algorithm #Anticoagulation
Algorithm for Evaluation of Suspected Pulmonary Embolism #Diagnosis #EM #IM #PCC #PulmonaryEmbolism #Pulmonary #Embolism #DDimer #CTA
Algorithm for Evaluation ... of Suspected Pulmonary ... Embolism #Diagnosis #EM ... #DDimer #CTA #Algorithm ... #Ddxof
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Lymphoma • Lung cancer ... & extrapulmonary ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Lymphoma • Lung cancer ... & extrapulmonary ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
syndromes current treatment ... algorithm 2018. ... influence outcomes and treatment ... cardiovascular or pulmonary ... #algorithm #hematology